Biotechnology

Finance professionals in Biotechnology

Explore how finance professionals in biotech actually decide where to spend money when development timelines slip, clinical trials cost more than expected, or manufacturing capacity runs short. Learn which budget choices they made, what data they used, and how they weighed speed against cost.

10 professionals10 companiesData retrieved September 27, 2026

Professionals to explore

01—10
  1. Abby Sheppard

    LinkedIn

    Experience: Financial Director · Azenta Life Sciences

    Has experience as a finance executive building scalable finance organisations and partnering with leadership on financial planning and analysis within pharmaceutical and biotech organisations.

  2. Caroline Wishart

    LinkedIn

    Experience: VP Finance Controller · Generate:Biomedicines

    Experience leading finance and accounting functions, including forecasting, budgeting, and financial reporting, at a biotechnology therapeutics company.

  3. Corey Sohmer

    LinkedIn

    Experience: VP Finance & Business Development · Actinium Pharmaceuticals, Inc.

    Experience leading finance and business development functions, including financial modeling, budgeting, and forecasting, in the biotechnology sector.

  4. Francois VanderMerwe

    LinkedIn

    Experience: FP&A Divisional R&D Controller · Roche

    Experience providing business planning guidance, product portfolio analysis, and variance analysis to a biotechnology company's diagnostics leadership and finance operating committee.

  5. Geraldine Hegarty

    LinkedIn

    Experience: Director, Controller · Ascidian Therapeutics

    Experience serving as Director and Controller managing financial models and reporting for a biotechnology company's R&D and clinical trial objectives.

  6. Jaimy Mauricio

    LinkedIn

    Experience: Sr. Director Financial Planning & Analysis · Intellia Therapeutics, Inc.

    Experience leading financial planning and analysis functions at a clinical-stage genome editing biotechnology company.

  7. Jamie Caswell

    LinkedIn

    Experience: Senior Director, FP&A · Vir Biotechnology, Inc.

    Experience in financial planning and analysis leadership, driving financial performance and controls-based approaches within the biotechnology sector.

  8. Lauren Fouquet

    LinkedIn

    Experience: Executive Director, Financial Planning & Analysis · Iovance Biotherapeutics, Inc.

    Experience in financial planning and analysis leadership, including strategic planning, budgeting, and forecasting, at a biotechnology company developing cancer therapies.

  9. Stephen Garbacz

    LinkedIn

    Experience: SVP Finance and Corporate Controller · Tessera Therapeutics

    Has experience leading finance and accounting functions, including public market readiness and financial operations, at a clinical-stage gene-editing biotechnology company.

  10. Yewande Fashakin

    LinkedIn

    Experience: Senior Director of Accounting and Finance Business Processes · BlueRock Therapeutics

    Has experience in accounting management and financial reporting at a clinical stage cell therapy biotechnology company, and prior similar roles at other biotech firms.

Choose the right perspective

Look for candidates who have built budgets or forecasts for specific biotech programs—drug development, manufacturing scale-up, or clinical trials. Ask them to describe a real budget decision they made or influenced, not general processes. The best candidates can explain the tradeoff they chose and why other options lost.

Questions to take into the conversation

  1. 01Walk me through a time when your budget forecast was wrong. What did you learn, and how did you change your next forecast?
  2. 02Tell me about a project where you had to choose between spending more money now or taking on schedule risk later. How did you make that call?
  3. 03When a development program needed more funding mid-year, what information did you use to decide whether to approve it or ask the team to cut scope?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Request a correction or removal

Other perspectives in Biotechnology